G.I. Windows is a clinical-stage company focused on biotechnology and healthcare, established in 2012. The company's goal is to engineer less invasive solutions for both surgeons and patients, aligning with their slogan "Engineering less invasive solutions for both surgeons and patients." G.I. Windows recently secured a significant $14.49M Venture Round investment on 29th June 2022. This investment will likely be instrumental in advancing the company's innovative solutions. The fact that the latest investment information does not disclose the specific investors involved leaves room for speculation about potential strategic partnerships and the confidence the investment community has in G.I. Windows. With its headquarters situated in the United States, the company is strategically positioned within a hub of medical and technological innovation.
GI Windows Surgical
Engineering less invasive solutions for both surgeons and patients.
United States
21 employees
Venture round
Total: $57.38M
Biotechnology, Health Care +1
General Information
United States
BounceWatch is an independent company data service, not affiliated with GI Windows Surgical. To contact GI Windows Surgical, visit giwindows.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does GI Windows Surgical compare?
A PDF of GI Windows Surgical and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting GI Windows Surgical soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is GI Windows Surgical on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About GI Windows Surgical
Business keywords: surgical innovation, minimally invasive surgery, clinical-stage company, anastomotic technology, diagnostic procedures, interventional procedures, healthcare cost reduction, medical device, surgical procedures, innovation, healthcare disruption
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $14.49M | - |
|
29 Jun 2022 |
| Series A | $16.40M | 4 |
|
19 Aug 2020 |
| Series A | $14.60M | 2 |
|
11 Dec 2019 |
| Series A | $9.50M | 1 |
|
13 Nov 2017 |
| Debt Financing | $2.39M | - |
|
24 Feb 2014 |
GI Windows Surgical Alternatives & Competitors
View All Alternatives
Elevating Expectations In Surgery
Blueneem is a Leader in Design, Development and End-to-end Manufacturing of Minimally-invasive Medic...
Pioneering compassionate, efficient, and minimally invasive tissue excision and biopsy for improved...
Centerline Biomedical
FAQ About GI Windows Surgical
Source: BounceWatch company record for GI Windows Surgical, https://www.bouncewatch.com/company/gi-windows, updated 30 December 2024. When citing, please name BounceWatch and link this page.
